From what I understand the grant went to the joint venture company which GRK owns 50:50 with an University. So It is only worth $3.5M directly to GRKI suspect a cap raising is next on the cards which is why my sentiment is hold
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential